🚀 VC round data is live in beta, check it out!
Kotra Industries Valuation Multiples
Discover revenue and EBITDA valuation multiples for Kotra Industries and similar public comparables like Kalaris Therapeutics, Curatis Holding, Humacyte, Heidelberg Pharma and more.
Kotra Industries Overview
About Kotra Industries
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
Founded
1982
HQ
Employees
713
Website
Sectors
Financials (LTM)
EV
$145M
Kotra Industries Financials
Kotra Industries reported last 12-month revenue of $55M and EBITDA of $15M.
In the same LTM period, Kotra Industries generated $15M in EBITDA and $10M in net income.
Revenue (LTM)
Kotra Industries P&L
In the most recent fiscal year, Kotra Industries reported revenue of $58M and EBITDA of $16M.
Kotra Industries expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $55M | XXX | $58M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $43M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 74% | XXX | XXX | XXX |
| EBITDA | $15M | XXX | $16M | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 28% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 21% | XXX | XXX | XXX |
| Net Profit | $10M | XXX | $11M | XXX | XXX | XXX |
| Net Margin | 18% | XXX | 18% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Kotra Industries Stock Performance
Kotra Industries has current market cap of $151M, and enterprise value of $145M.
Market Cap Evolution
Kotra Industries' stock price is $1.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $145M | $151M | 0.5% | XXX | XXX | XXX | $0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKotra Industries Valuation Multiples
Kotra Industries trades at 2.7x EV/Revenue multiple, and 9.9x EV/EBITDA.
EV / Revenue (LTM)
Kotra Industries Financial Valuation Multiples
As of April 17, 2026, Kotra Industries has market cap of $151M and EV of $145M.
Equity research analysts estimate Kotra Industries' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Kotra Industries has a P/E ratio of 15.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $151M | XXX | $151M | XXX | XXX | XXX |
| EV (current) | $145M | XXX | $145M | XXX | XXX | XXX |
| EV/Revenue | 2.7x | XXX | 2.5x | XXX | XXX | XXX |
| EV/EBITDA | 9.9x | XXX | 8.8x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 11.7x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.4x | XXX | XXX | XXX |
| P/E | 15.0x | XXX | 14.1x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 27.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Kotra Industries Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Kotra Industries Margins & Growth Rates
Kotra Industries' revenue in the last fiscal year grew by 1%.
Kotra Industries' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Kotra Industries Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 28% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (4%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 12% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 52% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Kotra Industries Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Kotra Industries | XXX | XXX | XXX | XXX | XXX | XXX |
| Kalaris Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Curatis Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| Humacyte | XXX | XXX | XXX | XXX | XXX | XXX |
| Heidelberg Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Galectin Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Kotra Industries M&A Activity
Kotra Industries acquired XXX companies to date.
Last acquisition by Kotra Industries was on XXXXXXXX, XXXXX. Kotra Industries acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Kotra Industries
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialKotra Industries Investment Activity
Kotra Industries invested in XXX companies to date.
Kotra Industries made its latest investment on XXXXXXXX, XXXXX. Kotra Industries invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Kotra Industries
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Kotra Industries
| When was Kotra Industries founded? | Kotra Industries was founded in 1982. |
| Where is Kotra Industries headquartered? | Kotra Industries is headquartered in Malaysia. |
| How many employees does Kotra Industries have? | As of today, Kotra Industries has over 713 employees. |
| Is Kotra Industries publicly listed? | Yes, Kotra Industries is a public company listed on Bursa Malaysia. |
| What is the stock symbol of Kotra Industries? | Kotra Industries trades under 0002 ticker. |
| When did Kotra Industries go public? | Kotra Industries went public in 2002. |
| Who are competitors of Kotra Industries? | Kotra Industries main competitors are Kalaris Therapeutics, Curatis Holding, Humacyte, Heidelberg Pharma. |
| What is the current market cap of Kotra Industries? | Kotra Industries' current market cap is $151M. |
| What is the current revenue of Kotra Industries? | Kotra Industries' last 12 months revenue is $55M. |
| What is the current EV/Revenue multiple of Kotra Industries? | Current revenue multiple of Kotra Industries is 2.7x. |
| Is Kotra Industries profitable? | Yes, Kotra Industries is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Kotra Industries? | Kotra Industries' last 12 months EBITDA is $15M. |
| What is Kotra Industries' EBITDA margin? | Kotra Industries' last 12 months EBITDA margin is 27%. |
| What is the current EV/EBITDA multiple of Kotra Industries? | Current EBITDA multiple of Kotra Industries is 9.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.